{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:29:49Z","timestamp":1778113789858,"version":"3.51.4"},"reference-count":31,"publisher":"American Psychiatric Association Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2003,1,1]]},"DOI":"10.1176\/appi.ajp.160.1.105","type":"journal-article","created":{"date-parts":[[2002,12,27]],"date-time":"2002-12-27T15:22:39Z","timestamp":1041002559000},"page":"105-111","source":"Crossref","is-referenced-by-count":266,"title":["Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial"],"prefix":"10.1176","volume":"160","author":[{"suffix":"Jr.","given":"Harrison G.","family":"Pope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey H.","family":"Cohane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James I.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1601CHDJGIBC","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, von M\u00fchlen DG, Kritz-Silverstein D: Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 1999; 84:573-577","DOI":"10.1210\/jcem.84.2.5495"},{"key":"R1601CHDJBFGH","doi-asserted-by":"crossref","unstructured":"Schweiger U, Deuschle M, Weber B, K\u00f6rner A, Lammers C-H, Schmider J, Gotthardt U, Heuser I: Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 1999; 61:292-296","DOI":"10.1097\/00006842-199905000-00007"},{"key":"R1601CHDGHJAA","doi-asserted-by":"crossref","unstructured":"Levitt AJ, Joffe RT: Total and free testosterone in depressed men. Acta Psychiatr Scand 1988; 77:346-348","DOI":"10.1111\/j.1600-0447.1988.tb05132.x"},{"key":"R1601CHDJJHFF","doi-asserted-by":"crossref","unstructured":"Seidman SN, Araujo AB, Roose SP, Devanand DP, Xie S, Cooper TB, McKinlay JB: Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry 2002; 159:456-459","DOI":"10.1176\/appi.ajp.159.3.456"},{"key":"R1601CHDGIADB","doi-asserted-by":"crossref","unstructured":"Booth A, Johnson DR, Granger DA: Testosterone and men\u2019s depression: the role of social behavior. J Health Soc Behav 1999; 40:130-140","DOI":"10.2307\/2676369"},{"key":"R1601CHDIJFJD","doi-asserted-by":"crossref","unstructured":"Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ: A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992; 13:297-304","DOI":"10.1002\/j.1939-4640.1992.tb00319.x"},{"key":"R1601CHDBIIAE","doi-asserted-by":"crossref","unstructured":"Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS: Testosterone replacement therapy improves mood in hypogonadal men\u2014a clinical research center study. J Clin Endocrinol Metab 1996; 81:3578-3583","DOI":"10.1210\/jcem.81.10.8855804"},{"key":"R1601CHDCHHAH","doi-asserted-by":"crossref","unstructured":"Rabkin JG, Wagner GJ, Rabkin R: A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000; 57:141-147","DOI":"10.1001\/archpsyc.57.2.141"},{"key":"R1601CHDDABDC","doi-asserted-by":"crossref","unstructured":"Grinspoon S, Corcoran C, Stanley T, Baaj A, Basgoz N, Klibanski A: Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab 2000; 85:60-65","DOI":"10.1210\/jc.85.1.60"},{"key":"R1601CHDBGFJH","doi-asserted-by":"crossref","unstructured":"Altschule MD, Tillotson KJ: The use of testosterone in the treatment of depressions. N Engl J Med 1948; 239:1036-1038","DOI":"10.1056\/NEJM194812302392704"},{"key":"R1601CHDIDCBF","unstructured":"Itil TM, Michael ST, Shapiro DM, Itil KZ: The effects of mesterolone, a male sex hormone in depressed patients (a double-blind controlled study). Methods Find Exp Clin Pharmacol 1984; 6:331-337"},{"key":"R1601CHDFBBHH","unstructured":"Vogel W, Klaiber EL, Braverman DM: A comparison of the antidepressant effect of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry 1985; 46:6-8"},{"key":"R1601CHDJBHEJ","doi-asserted-by":"crossref","unstructured":"Seidman SN, Rabkin J: Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord 1998; 48:157-161","DOI":"10.1016\/S0165-0327(97)00168-7"},{"key":"R1601CHDDGEJH","doi-asserted-by":"crossref","unstructured":"Seidman SN, Spatz E, Rizzo C, Roose SP: Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry 2001; 62:406-412","DOI":"10.4088\/JCP.v62n0602"},{"key":"R1601CHDFDDHJ","doi-asserted-by":"crossref","unstructured":"Cunningham GR, Cordero E, Thornby JI: Testosterone replacement with transdermal therapeutic systems: physiological serum testosterone levels and elevated dihydrotestosterone levels. JAMA 1989; 261:2525-2530","DOI":"10.1001\/jama.261.17.2525"},{"key":"R1601CHDHEADH","doi-asserted-by":"crossref","unstructured":"Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli AE, Mazer NA: Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999; 84:3469-3478","DOI":"10.1210\/jcem.84.10.6078"},{"key":"R1601CHDGBBFD","doi-asserted-by":"crossref","unstructured":"Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N: Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000; 85:2839-2853","DOI":"10.1210\/jc.85.8.2839"},{"key":"R1601CHDDIAEC","doi-asserted-by":"crossref","unstructured":"Haupt HA, Rovere GD: Anabolic steroids: a review of the literature. Am J Sports Med 1984; 12:469-484","DOI":"10.1177\/036354658401200613"},{"key":"R1601CHDJCHCJ","doi-asserted-by":"crossref","unstructured":"Winters SJ: Diurnal rhythm of testosterone and luteinizing hormone in hypogonadal men. J Androl 1991; 12:185-190","DOI":"10.1002\/j.1939-4640.1991.tb00247.x"},{"key":"R1601CHDEFAFC","doi-asserted-by":"crossref","unstructured":"Barry MJ, Fowler FJ Jr, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT (Measurement Committee of the American Urological Association): The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148:1549-1557","DOI":"10.1016\/S0022-5347(17)36966-5"},{"key":"R1601CHDGHIAF","doi-asserted-by":"crossref","unstructured":"Kouri EM, Pope HG Jr, Katz DL, Oliva PS: Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clin J Sport Med 1995; 5:223-228","DOI":"10.1097\/00042752-199510000-00003"},{"key":"R1601CHDHFGCH","doi-asserted-by":"crossref","unstructured":"Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, Shea MT, Imber SD, Sotsky SM, Watkins JT: Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50:739-750","DOI":"10.1001\/archpsyc.1993.01820210073009"},{"key":"R1601CHDGBGHD","doi-asserted-by":"crossref","unstructured":"Vermeulen A, Kaufman JM, Giagulli VA: Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996; 81:1821-1826","DOI":"10.1210\/jcem.81.5.8626841"},{"key":"R1601CHDDAAHJ","doi-asserted-by":"crossref","unstructured":"Daly RC, Schmidt PJ, Roca CA, Rubinow DR: Testosterone\u2019s effects not limited to mood. Arch Gen Psychiatry 2001; 58:403-404","DOI":"10.1001\/archpsyc.58.4.403"},{"key":"R1601CHDGBEBC","doi-asserted-by":"crossref","unstructured":"Daly RC, Su TP, Schmidt PJ, Pickar D, Murphy DL, Rubinow DR: Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings. Arch Gen Psychiatry 2001; 58:172-177","DOI":"10.1001\/archpsyc.58.2.172"},{"key":"R1601CHDGCGJC","doi-asserted-by":"crossref","unstructured":"Mulchahey JJ, Ekhator NN, Zhang H, Kasckow JW, Baker DG, Geracioti TD Jr: Cerebrospinal fluid and plasma testosterone levels in post-traumatic stress disorder and tobacco dependence. Psychoneuroendocrinology 2001; 26:273-285","DOI":"10.1016\/S0306-4530(00)00052-4"},{"key":"R1601CHDFGIAB","doi-asserted-by":"crossref","unstructured":"Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA: Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343:682-688","DOI":"10.1056\/NEJM200009073431002"},{"key":"R1601CHDIEGAB","doi-asserted-by":"crossref","unstructured":"Wilson IC, Prange AJ Jr, Lara PP: Methyltestosterone with imipramine in men: conversion of depression to paranoid reaction. Am J Psychiatry 1974; 131:21-24","DOI":"10.1176\/ajp.131.1.21"},{"key":"R1601CHDFEIFC","doi-asserted-by":"crossref","unstructured":"Rolf C, Nieschlag E: Potential adverse effects of long-term testosterone therapy. Bailli\u00e8res Clin Endocrinol Metab 1998; 12:521-534","DOI":"10.1016\/S0950-351X(98)80305-4"},{"key":"R1601CHDHDGGI","doi-asserted-by":"crossref","unstructured":"Guay AT, Perez JB, Fitaihi WA, Vereb M: Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer. Endocr Pract 2000; 6:132-138","DOI":"10.4158\/EP.6.2.132"},{"key":"R1601CHDGFGEC","doi-asserted-by":"crossref","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19","DOI":"10.1001\/archpsyc.1994.03950010008002"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.1.105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T01:06:42Z","timestamp":1722388002000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.1.105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1,1]]}},"alternative-id":["10.1176\/appi.ajp.160.1.105"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.160.1.105","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,1]]}}}